Researcher.Life Logo

Clinical and Molecular Hepatology : Impact Factor & More

eISSN: 2287-285XpISSN: 2287-2728
JournalOpen Access

Key Metrics

CiteScore
8.9
Eigenfactor
0.001 - 0.005
H-Index
49
Impact Factor
5 - 10
SJR
Q1Hepatology
SNIP
1.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Molecular Hepatology

Clinical and Molecular Hepatology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher KOREAN ASSOC STUDY LIVER
Language English
Frequency Quarterly
Article Processing ChargesKRW 42000
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Clinical and Molecular Hepatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Molecular Hepatology

Beyond the Single Model: Critical Considerations for Translating HCC Triplet Immunotherapy from Bench to Bedside.
  • 26 Dec 2025
  • Clinical and molecular hepatology
Comment on the expert consensus on treatment approaches for achieving functional cure in chronic hepatitis B.
  • 26 Dec 2025
  • Clinical and molecular hepatology
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
  • 26 Dec 2025
  • Clinical and molecular hepatology
MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD.
  • 26 Dec 2025
  • Clinical and molecular hepatology
Correspondence to editorial "Mechanistic Insights into a Noncanonical RAB25-GCN1 axis in ALD: on RAB25/GCN1 signaling promotes ER stress to mediate alcohol-associated liver disease progression".
  • 23 Dec 2025
  • Clinical and molecular hepatology
Correspondence to the editorial "Berberine and the gut microbiota - A novel treatment strategy for cholestatic liver disease".
  • 23 Dec 2025
  • Clinical and molecular hepatology
Beyond the Single Model: Critical Considerations for Translating HCC Triplet Immunotherapy from Bench to Bedside.
  • 26 Dec 2025
  • Clinical and molecular hepatology
Comment on the expert consensus on treatment approaches for achieving functional cure in chronic hepatitis B.
  • 26 Dec 2025
  • Clinical and molecular hepatology
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
  • 26 Dec 2025
  • Clinical and molecular hepatology
MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD.
  • 26 Dec 2025
  • Clinical and molecular hepatology
Correspondence to editorial "Mechanistic Insights into a Noncanonical RAB25-GCN1 axis in ALD: on RAB25/GCN1 signaling promotes ER stress to mediate alcohol-associated liver disease progression".
  • 23 Dec 2025
  • Clinical and molecular hepatology
Correspondence to the editorial "Berberine and the gut microbiota - A novel treatment strategy for cholestatic liver disease".
  • 23 Dec 2025
  • Clinical and molecular hepatology

FAQs on Clinical and Molecular Hepatology